Association of White Blood Cell Count with Treatment Response to…
A simple blood test at treatment start may help doctors choose between two common sepsis antibiotics, potentially improving survival in critically ill patients.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Clinical evidence of semaglutide for metabolic dysfunction-associated…
Semaglutide shows promise for resolving fatty liver inflammation in people with metabolic dysfunction, though longer studies are needed to confirm benefits for advanced scarring.
Underserved or high-risk populationsCirculating IGF2BP3 enables risk stratification and predicts…
A new blood test detecting a cancer protein offers pediatricians an affordable way to better predict outcomes and guide treatment decisions in Ewing sarcoma.
Underserved or high-risk populationsPatient and oncologist expectations of functional prognosis among…
An educational video and assessment tool successfully helped older leukemia patients and doctors align on realistic recovery expectations, improving shared decision-making.
Promising but preliminaryPrognostic significance of therapy-induced senescence and SASP…
Cells damaged by leukemia treatment create a toxic environment that predicts poor survival, suggesting new drug targets to eliminate these lingering cells.